- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
XORTX Therapeutics Inc (XRTX)
XORTX Therapeutics Inc stock price live, this page displays NASDAQ XRTX stock exchange data. View the XRTX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the XORTX Therapeutics Inc real time stock price chart below.
What Is the XORTX Therapeutics Inc Stock Price Today?
The XORTX Therapeutics Inc stock price today is 0.4250.
What Is the Stock Symbol for XORTX Therapeutics Inc?
The stock symbol for XORTX Therapeutics Inc is ""XRTX.""
What Stock Exchange Does XORTX Therapeutics Inc Trade On?
XORTX Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is XORTX Therapeutics Inc a Good Stock to Buy?
Determining whether XORTX Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the XRTX quote. (ISIN: CA98420Q3061)
What Is the XORTX Therapeutics Inc Stock Price Today?
The XORTX Therapeutics Inc stock price today is 0.4250.
What Is the Stock Symbol for XORTX Therapeutics Inc?
The stock symbol for XORTX Therapeutics Inc is ""XRTX.""
What Stock Exchange Does XORTX Therapeutics Inc Trade On?
XORTX Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is XORTX Therapeutics Inc a Good Stock to Buy?
Determining whether XORTX Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the XRTX quote. (ISIN: CA98420Q3061)
0.4250
-0.0099(-2.28%)
Real-time Data·
Fair Value
An estimate of a XORTX Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.4005
0.4250
52 wk Range
0.3820
1.4100
XRTX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a XORTX Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.40050.4250
52 wk Range
0.38201.4100
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
XRTX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a XORTX Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- Form 6K XORTX Therapeutics Inc For: 29 October
- Investing.com
- Form 6K XORTX Therapeutics Inc For: 2 January
- Investing.com
- XORTX closes $1.1 million registered direct offering
- Investing.com
- Form 6K XORTX Therapeutics Inc For: 2 January
- Investing.com
- Form 6K XORTX Therapeutics Inc. For: 17 November
- Investing.com
- Form 6K XORTX Therapeutics Inc For: 31 October
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
XORTX Therapeutics Inc Company Profile
XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease. Its drug development programs include XRx-026, which is in the third phase for the treatment of gout; XRx-008, which is in the second phase to treat autosomal dominant polycystic kidney disease; XRx-101, which is in the second phase to treat acute kidney injury associated with respiratory virus infection; and XRX-225, which is in the preclinical stage for the treatment of type 2 diabetic nephropathy. It has a license agreement with the University of Florida Research Foundation, Inc. for the use of uric acid lowering agent to treat insulin resistance. The company is based in Calgary, Canada.
Compare XRTX to Peers and Sector
Metrics to compare | XRTX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipXRTXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.5x | −1.4x | −0.5x | |
PEG Ratio | 0.02 | 0.15 | 0.00 | |
Price/Book | 1.5x | 1.7x | 2.6x | |
Price / LTM Sales | - | 1.9x | 3.3x | |
Upside (Analyst Target) | - | 71.1% | 47.0% | |
Fair Value Upside | Unlock | 12.8% | 5.7% | Unlock |
Earnings
Latest Release
Nov 15, 2025
EPS / Forecast
-0.13 / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the XORTX Therapeutics (XRTX) Stock Price Today?
The XORTX Therapeutics stock price today is 0.4250.
What Stock Exchange Does XORTX Therapeutics Trade On?
XORTX Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for XORTX Therapeutics?
The stock symbol for XORTX Therapeutics is "XRTX."
What Is the XORTX Therapeutics (XRTX) Afterhours Price Today? (Afterhours variable test: 0.4333) Current Date: Feb 17, 2026
After hours price: 0.4333. After hours price change (units): -0.0016. Price change percentage: -0.3700%
What Is the XORTX Therapeutics Market Cap?
As of today, XORTX Therapeutics market cap is 2.9100M.
What Is XORTX Therapeutics's Earnings Per Share (TTM)?
The XORTX Therapeutics EPS (TTM) is -0.4961.
From a Technical Analysis Perspective, Is XRTX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has XORTX Therapeutics Stock Split?
XORTX Therapeutics has split 2 times.
What is the current trading status of XORTX Therapeutics (XRTX)?
As of Feb 17, 2026, XORTX Therapeutics (XRTX) is trading at a price of 0.4250, with a previous close of 0.4349. The stock has fluctuated within a day range of 0.4005 to 0.4250, while its 52-week range spans from 0.3820 to 1.4100.
What Is the XRTX After Hours Price?
XRTX's last after hours stock price is 0.4333, the stock has decreased by -0.0016, or -0.3700%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.